S.Y. Yeung, M.J. Piggott
Fitoterapiaxxx(xxxx)xxx–xxx
effect of Antrodia camphorata, or that a metabolite of the natural pro-
duct is responsible for its in vivo activity anticancer activity, cannot be
ruled out at this stage.
O
O
O
4. Experimental
4.1. General details
4,7-Dimethoxybenzo[d][1,3]dioxole-5-carbaldehyde
(apiolalde-
O
hyde) (4) and 4,7-dimethoxy-5-methylbenzo[d][1,3]dioxole (1) were
synthesised as described previously [40]. Solvents were distilled before
use. ‘Petrol’ refers to the hydrocarbon fraction distilling from 64 to
67 °C; DCM = dichloromethane. Anhydrous THF (tetrahydrofuran) was
obtained from a Pure Solv 5-Mid Solvent Purification System (In-
novative Technology Inc.). All other reagents and materials were pur-
chased from commercial suppliers and used as received.
1
Fig. 1. Structure of the bioactive natural product 4,7-dimethoxy-5-methylbenzo
[d][1,3]dioxole.
The natural product 1 and analogues 4, 6–9 were assessed for an-
tiproliferative activity in the US National Cancer Institute's Human
Tumour Cell Lines Screen (NCI-60) [54] at 10 μM. Selected results are
presented in Table 1 (see Supporting information for the complete da-
taset).
Reaction progress was monitored by analytical thin layer chroma-
tography (TLC) using Merck aluminium-backed TLCF254 plates. Spots
were visualised with a UV lamp (254 nm). Organic extracts were dried
over anhydrous MgSO4. Solvents were evaporated under reduced
pressure at approximately 45 °C, and then traces of solvent were re-
moved under a flow of nitrogen.
Unfortunately, neither the natural product nor any of the analogues
showed sufficient activity against any of the 60 cell lines to warrant IC50
determinations, and any interpretation of structure–activity relation-
ships based on testing at a single concentration is therefore tentative.
Surprisingly, neither the natural product 1, which has been reported to
“profoundly decreased the growth of COLO-205 human colon cancer
cell tumor xenografts in an athymic nude mouse model” [48], nor any
of the analogues inhibited the growth of this cell line at 10 μM. The
natural product 1 was most active against SR and UO-31 cell lines,
which derive from leukemia and a renal tumour, respectively. Indeed
all analogues modestly inhibited the growth of these cell lines, with the
exception of the nitrile 8, which actually slightly promoted the growth
of UO-31 cells. In contrast, the nitrile 8 most potently inhibited the
growth of HL-60(TB) (leukemia) and HOP-92 (non-small cell lung
cancer) cell lines.
1H and 13C NMR spectra were obtained using a Varian Gemini-400
(400 MHz, 1H, 100 MHz, 13C), spectrometer. Deuterochloroform
(CDCl3) was used as the solvent, with residual CHCl3 (1H,
δ = 7.26 ppm) or CDCl3 (
13C, δ = 77.16 ppm) being used for calibra-
tion.
The infrared spectrum was recorded on a neat sample using a
Perkin-Elmer Spectrum One FT-IR spectrometer with Attenuated Total
Reflectance (ATR). Melting points were determined on a Reichert hot
stage melting point apparatus.
4.2. Synthesis
4.2.1. 4,7-Dimethoxybenzo[d][1,3]dioxole-5-carboxylic acid (apiolic
acid) (6)
Sulfamic acid (0.39 g, 1.0 mmol) was added to a stirred solution of
aldehyde 4 (0.10 g, 1.0 mmol) in acetone/water (3:1) (5 mL), followed
by sodium chlorite (0.14 g, 1.5 mmol). After 2 h, the reaction mixture
was diluted with DCM (100 mL) and the organic phase was washed
with brine (3 × 100 mL). The aqueous phase was extracted with DCM
(50 mL) and the combined organic phase was dried and evaporated to
give the carboxylic acid 6 as yellow solid (0.19 g, 83%), which crys-
tallized from DCM as off-white needles, mp = 176–178 °C [lit
[55]. = 176 °C]. Rf = 0.2 (1:1 petrol/EtOAc); 1H NMR (400 MHz,
CDCl3): δ 7.36 (s, 1H, ArH), 6.10 (s, 2H, OCH2O), 4.14 (s, 3H, OCH3),
3.88 (s, 3H, OCH3); 13C NMR (100 MHz, CDCl3): 165.3 (CHO), 141.7
3. Conclusion
The benzodioxole natural product 1, which has been reported to
have anticancer potential, and a small series of more polar analogues,
were synthesised and assessed for antiproliferative activity in the NCI-
60 screen. None of the compounds showed any significant activity at
10 μM. Hence, although 1 should not necessarily be abandoned as in-
spiration for the discovery of anticancer agents, substantial improve-
ments in potency of analogues will be required to identify a genuine
lead. The possibility that 1 contributes synergistically to an anticancer
O
O
H2 , Pd/C
O
O
O
O
O
O
O
O
O
O
O
O
CHO
AcOH
•
NaBO3 4H2O
O
O
O
1
TFA
O
O
2
3
4
O
O
O
O
O
O
O
5
Scheme 1. Previous synthesis of natural products 1 and 5[40].
2